Open original FDA record ↗Recall record
- FDA identifier
- Z-0104-2023
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc.
- FDA classification date
- Oct 20, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for falsely elevated LITH_2 and Li results on the Atellica CH 930 Analyzer. In the worst case, there is a potential for erroneously elevated lithium patient results, which may lead to inappropriate dosage adjustment, potentially affecting treatment efficacy.
Source facts
- Action
- On September 19, 2022, the firm issued an Urgent Medical Device Correction letter to affected customers. Customers should take the following actions: -Please review this letter with your Medical Director. -Discontinue use of and discard the affected product. Siemens is temporarily discontinuing production and distribution of the Atellica CH lithium reagents until the issue is resolved. In the interim, Siemens is recommending that customers transition to an alternate lithium assay.
- Initiated
- 2022-09-19
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution - US Nationwide.
- Recall number
- Z-0104-2023
- Recall status
- Open, Classified
- CDRH record ID
- 196168
- FDA classified
- 2022-10-20
- Recall event number
- 90900